| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |